Most recent research published on psychedelic therapy for autism

Research on the use of psychedelic therapy for autism is still in the early stages, and currently, there is a lack of robust scientific evidence to support its use as a treatment for autism. While some studies have suggested that psychedelic substances such as psilocybin and LSD may have therapeutic potential for treating symptoms of autism, such as anxiety and social isolation, these studies have been small and have not been conducted using rigorous scientific methods. Additionally, the use of psychedelics is still considered experimental and it is important to note that their effects are not yet fully understood, and there are potential risks and side effects associated with their use. Furthermore, the use of psychedelics is illegal in many countries and regions, which makes it difficult to conduct research in this field. It is important to note that more research is needed to establish the safety and efficacy of psychedelic therapy as a treatment for autism. Until more rigorous scientific studies are conducted, it is not recommended to use psychedelics as a treatment for autism. It's always recommended to consult with a healthcare professional before starting any new treatment and to follow the guidelines and regulations.